Concepts (80)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Clostridium Infections | 16 | 2024 | 56 | 3.430 |
Why?
|
| Feces | 5 | 2025 | 26 | 1.360 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2024 | 20 | 0.910 |
Why?
|
| Sensitivity and Specificity | 1 | 2024 | 136 | 0.880 |
Why?
|
| Anti-Bacterial Agents | 10 | 2025 | 183 | 0.880 |
Why?
|
| Ribotyping | 9 | 2022 | 26 | 0.730 |
Why?
|
| Tetracyclines | 4 | 2025 | 15 | 0.500 |
Why?
|
| Cross Infection | 3 | 2021 | 19 | 0.490 |
Why?
|
| Bacterial Toxins | 4 | 2024 | 16 | 0.470 |
Why?
|
| Humans | 17 | 2025 | 5476 | 0.390 |
Why?
|
| Vancomycin | 3 | 2025 | 28 | 0.340 |
Why?
|
| Microbial Sensitivity Tests | 4 | 2024 | 99 | 0.300 |
Why?
|
| Diarrhea | 2 | 2019 | 23 | 0.300 |
Why?
|
| Bile Acids and Salts | 2 | 2025 | 9 | 0.280 |
Why?
|
| Gastrointestinal Microbiome | 2 | 2024 | 20 | 0.250 |
Why?
|
| Fatty Acids, Volatile | 1 | 2025 | 5 | 0.230 |
Why?
|
| DNA, Bacterial | 1 | 2024 | 10 | 0.230 |
Why?
|
| Spores, Bacterial | 2 | 2022 | 24 | 0.220 |
Why?
|
| Bacterial Proteins | 1 | 2024 | 58 | 0.220 |
Why?
|
| Purine Nucleosides | 1 | 2024 | 3 | 0.220 |
Why?
|
| Anti-Infective Agents | 1 | 2024 | 15 | 0.210 |
Why?
|
| Fusobacterium Infections | 1 | 2022 | 3 | 0.200 |
Why?
|
| Fusobacteria | 1 | 2022 | 3 | 0.200 |
Why?
|
| Female | 8 | 2025 | 2811 | 0.190 |
Why?
|
| Pseudomonas Infections | 1 | 2022 | 19 | 0.190 |
Why?
|
| Pseudomonas aeruginosa | 1 | 2022 | 34 | 0.190 |
Why?
|
| Fecal Microbiota Transplantation | 1 | 2021 | 2 | 0.180 |
Why?
|
| Genotype | 1 | 2021 | 58 | 0.180 |
Why?
|
| Cell Wall | 1 | 2021 | 13 | 0.180 |
Why?
|
| Male | 7 | 2025 | 2765 | 0.170 |
Why?
|
| Microbiota | 1 | 2020 | 18 | 0.170 |
Why?
|
| Middle Aged | 5 | 2025 | 1098 | 0.170 |
Why?
|
| Hospitals | 1 | 2019 | 10 | 0.160 |
Why?
|
| Dog Diseases | 1 | 2019 | 3 | 0.160 |
Why?
|
| Animals, Zoo | 1 | 2019 | 3 | 0.160 |
Why?
|
| Environmental Microbiology | 1 | 2019 | 9 | 0.150 |
Why?
|
| Healthy Volunteers | 3 | 2025 | 42 | 0.150 |
Why?
|
| Adult | 5 | 2025 | 1683 | 0.150 |
Why?
|
| Whole Genome Sequencing | 1 | 2018 | 12 | 0.150 |
Why?
|
| Bangladesh | 3 | 2022 | 6 | 0.130 |
Why?
|
| Molecular Epidemiology | 3 | 2020 | 7 | 0.120 |
Why?
|
| Polymerase Chain Reaction | 3 | 2020 | 38 | 0.120 |
Why?
|
| Prevalence | 2 | 2022 | 72 | 0.090 |
Why?
|
| Texas | 2 | 2020 | 190 | 0.070 |
Why?
|
| Aged | 2 | 2021 | 859 | 0.070 |
Why?
|
| Chenodeoxycholic Acid | 1 | 2025 | 4 | 0.060 |
Why?
|
| Chromatography, Liquid | 1 | 2025 | 38 | 0.060 |
Why?
|
| Metronidazole | 1 | 2024 | 15 | 0.050 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2025 | 68 | 0.050 |
Why?
|
| Pyridines | 1 | 2023 | 24 | 0.050 |
Why?
|
| Anaerobiosis | 1 | 2022 | 6 | 0.050 |
Why?
|
| DNA-Directed DNA Polymerase | 1 | 2022 | 2 | 0.050 |
Why?
|
| Tertiary Care Centers | 1 | 2022 | 6 | 0.050 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2022 | 20 | 0.050 |
Why?
|
| Carbapenems | 1 | 2022 | 8 | 0.050 |
Why?
|
| Hospital Mortality | 1 | 2021 | 9 | 0.050 |
Why?
|
| Treatment Failure | 1 | 2021 | 7 | 0.050 |
Why?
|
| Prognosis | 1 | 2021 | 59 | 0.050 |
Why?
|
| Hospitalization | 1 | 2021 | 38 | 0.050 |
Why?
|
| Escherichia coli | 1 | 2022 | 111 | 0.040 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2021 | 52 | 0.040 |
Why?
|
| Genetic Variation | 1 | 2021 | 36 | 0.040 |
Why?
|
| Double-Blind Method | 1 | 2020 | 34 | 0.040 |
Why?
|
| Administration, Oral | 1 | 2020 | 35 | 0.040 |
Why?
|
| Young Adult | 1 | 2025 | 850 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2020 | 53 | 0.040 |
Why?
|
| Bacteria | 1 | 2021 | 52 | 0.040 |
Why?
|
| Kinetics | 1 | 2020 | 79 | 0.040 |
Why?
|
| Bacterial Typing Techniques | 1 | 2020 | 3 | 0.040 |
Why?
|
| Aged, 80 and over | 1 | 2021 | 320 | 0.040 |
Why?
|
| Mutation | 1 | 2021 | 137 | 0.040 |
Why?
|
| Public Health Surveillance | 1 | 2019 | 2 | 0.040 |
Why?
|
| Bacteriological Techniques | 1 | 2019 | 6 | 0.040 |
Why?
|
| Retrospective Studies | 1 | 2021 | 382 | 0.040 |
Why?
|
| Dogs | 1 | 2019 | 17 | 0.040 |
Why?
|
| Urban Population | 1 | 2019 | 18 | 0.040 |
Why?
|
| Multilocus Sequence Typing | 1 | 2018 | 4 | 0.040 |
Why?
|
| Disease Outbreaks | 1 | 2018 | 5 | 0.040 |
Why?
|
| Long-Term Care | 1 | 2018 | 5 | 0.040 |
Why?
|
| Animals | 1 | 2019 | 1817 | 0.020 |
Why?
|